Evidence map›Paper›PMID 9742113›Full record

ArticleMolecular and cellular biology1998

myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome.

E M Flinn, C M Busch, A P Wright

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 132 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Gene Transactivation and Transrepression in MYC-Driven Cancers.International journal of molecular sciences · 2021
    Review
  9. Review
  10. Review
  11. MYC leads the way.Small GTPases · 2020
    Review
  12. Review
  13. Mission Possible: Advances in MYC Therapeutic Targeting in Cancer.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2019
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. MYC degradation.Cold Spring Harbor perspectives in medicine · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

E M FlinnKarolinska Institute, Department of Biosciences, NOVUM, S-14157 Huddinge, Sweden. elizabeth.flinn@cbt.ki.se
C M Busch
A P Wright
Karolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular levels of the rapidly degraded c-myc protein play an important role in determining the proliferation status of cells. Increased levels of c-myc are frequently associated with rapidly proliferating tumor cells. We show here that myc boxes I and II, found in the N termini of all members of the myc protein family, function to direct the degradation of the c-myc protein. Both myc boxes I and II contain sufficient information to independently direct the degradation of otherwise stably expressed proteins to which they are fused. At least part of the myc box-directed degradation occurs via the proteasome. The mechanism of myc box-directed degradation appears to be conserved between yeast and mammalian cells. Our results suggest that the myc boxes may play an important role in regulating the level and activity of the c-myc protein.

Indexed as

AnimalsCOS CellsCysteine EndopeptidasesMultienzyme ComplexesProteasome Endopeptidase ComplexProto-Oncogene Proteins c-mycReceptors, GlucocorticoidRNA, MessengerCysteine EndopeptidasesMultienzyme ComplexesProteasome Endopeptidase ComplexProto-Oncogene Proteins c-mycReceptors, GlucocorticoidRNA, Messenger

Identifiers

PMID9742113
PMCPMC109182
OpenAlexW2162511924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.